Lawrence C. Panasci
3755 Cote Sainte Catherine Rd.
Montreal, Canada
Montreal, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 07, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2025
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre.
Journal: Current oncology (Toronto, Ont.)
Published: October 15, 2024
High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer.
Journal: Clinical breast cancer
Published: October 08, 2024
Placental metastasis from maternal NUT carcinoma: diagnostic pitfalls and challenges.
Journal: BMJ case reports
Published: April 03, 2024
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.
Journal: Breast (Edinburgh, Scotland)
Published: February 03, 2023
PARP Inhibition Sensitizes Breast Cancer Cells to Eribulin.
Journal: Frontiers in bioscience (Landmark edition)
Published: October 17, 2022
The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 04, 2021
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 11, 2020
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.
Journal: Breast cancer research and treatment
Published: January 12, 2018
A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.
Journal: Breast cancer research and treatment
Published: October 04, 2017
Precision spherical nucleic acids for delivery of anticancer drugs.
Journal: Chemical science
Published: April 11, 2017
Last Updated: 09/26/2026